用他人的大脑为药厂做长期 Beta 测试Turning Human Brains into Long-term Beta Tests for Big Pharma
15% 的风险降低，在药厂的 PR 话术里是“潜在的重要性”，在结构层面上则是极其精准的 market expansion。当一项研究建议将 statins（他汀类药物）作为一种“预防套餐”推广给所有人时，我们面对的不是医疗进步，而是一场关于“正常人体”定义的认知战争。
注意这个逻辑：先定义 LDL-C（低密度脂蛋白胆固醇）为风险因子，然后将药物干预提前到 midlife 甚至更早。这意味着一个原本健康的人，在没有任何症状时，就被定义为“潜在的病人”。这种从“治疗”到“预防”的叙事漂移，本质上是在扩张药厂的认知入口，将整个成年人群体转化为长期的订阅用户。
最值得警惕的是这种 observational study（观察性研究）的共谋机制。研究者指出相关性而非因果性，但媒体和专家却在迅速将其转化为“建议”。这种模糊地带为药厂提供了完美的掩护：他们不需要证明药物能 100% 治愈痴呆，只需要制造一种“如果不吃药，你就在承担风险”的恐惧叙事。这就是典型的 weaponized expression，利用对衰老和失智的恐惧，将药物依赖合法化。
所谓的“廉价且普及”是最高级的诱饵。当一种药物变得廉价到可以被全民服用时，它就不再是医疗资源，而是一种结构性的生物规训。我们正在进入一个时代，健康不再是身体的自然状态，而是一系列化学干预后的“维持状态”。
A 15% risk reduction is framed as "potentially important" in pharma PR, but structurally, it is a precise exercise in market expansion. When research suggests offering statins to everyone as a "preventative package," we aren't witnessing medical progress, but a cognitive war over the definition of a "normal" human body.
Observe the logic: first, define LDL-C as a risk factor, then push pharmacological intervention back to midlife or earlier. This transforms a healthy individual into a "potential patient" long before any symptoms appear. This narrative shift from "treatment" to "prevention" is essentially an expansion of the cognitive entry point for pharma, turning the entire adult population into long-term subscribers.
The most alarming part is the mechanism of complicity within these observational studies. Researchers claim association rather than causation, yet the media and experts rapidly translate this into "recommendations." This ambiguity provides perfect cover for Big Pharma: they don't need to prove the drug cures dementia; they only need to manufacture a narrative of fear—that without the drug, you are "at risk." This is textbook weaponized expression, using the terror of aging and cognitive decline to legitimize drug dependency.
Being "inexpensive and widely available" is the ultimate bait. When a drug becomes cheap enough for universal consumption, it ceases to be a medical resource and becomes a form of structural biological discipline. We are entering an era where health is no longer the natural state of the body, but a "maintained state" achieved through continuous chemical intervention.